CD4 1 T helper cells are well known for their role in providing critical signals during priming of cytotoxic CD8 1 T lymphocyte (CTL) responses in vivo. T-cell help is required for the generation of primary CTL responses as well as in promoting protective CD8 1 memory T-cell development 1 . However, the role of CD4 help in the control of CTL responses at the effector stage is unknown. Here we show that fully helped effector CTLs are themselves not selfsufficient for entry into the infected tissue, but rely on the CD4 1 T cells to provide the necessary cue. CD4 1 T helper cells control the migration of CTL indirectly through the secretion of IFN-c and induction of local chemokine secretion in the infected tissue. Our results reveal a previously unappreciated role of CD4 help in mobilizing effector CTL to the peripheral sites of infection where they help to eliminate infected cells.
CD4 1 T helper cells are well known for their role in providing critical signals during priming of cytotoxic CD8 1 T lymphocyte (CTL) responses in vivo. T-cell help is required for the generation of primary CTL responses as well as in promoting protective CD8 1 memory T-cell development 1 . However, the role of CD4 help in the control of CTL responses at the effector stage is unknown. Here we show that fully helped effector CTLs are themselves not selfsufficient for entry into the infected tissue, but rely on the CD4 1 T cells to provide the necessary cue. CD4 1 T helper cells control the migration of CTL indirectly through the secretion of IFN-c and induction of local chemokine secretion in the infected tissue. Our results reveal a previously unappreciated role of CD4 help in mobilizing effector CTL to the peripheral sites of infection where they help to eliminate infected cells.
Elimination of invading pathogens often requires coordinated effort by effector lymphocytes for containment and clearance. Successful defence against intracellular pathogens requires neutralizing antibodies and CTL responses, both of which largely depend on CD4 1 T-cell help. Whereas the generation of primary CD8 1 T-cell responses to noninflammatory antigens [2] [3] [4] and certain virus infections, such as herpes simplex virus (HSV) 5 , require CD4 1 T-cell help, primary CTL responses to acute infection with Listeria monocytogenes and lymphocytic choriomeningitis virus can occur in the absence of CD4 1 T cells. Instead, the latter type of infections requires CD4 help in promoting memory CTL development [6] [7] [8] . The critical role of CD4 help in the priming and maintenance of CTL responses is well characterized; however, whether CD4 1 T cells help at the stages after CTL differentiation has not been described and is at present unknown.
To explore the role of CD4 help in effector CTL responses, we used a physiological model of local virus infection that enables tracking of antigen-specific CD8 1 T cells. HSV-2 infects humans through sexual contact and causes genital herpes. When inoculated into the vaginal cavity, HSV-2 replicates predominantly in the mucosal epithelial cells and establishes latency in the innervating neurons. Because the viral infection is localized, the genital herpes model enabled us to dissect the role of CD4 help in CTL migration to the site of infection. To avoid neurovirulence associated with wild-type HSV-2, without compromising the ability to prime robust innate and adaptive immunity, we used thymidine-kinase (TK)-defective HSV-2 (TK 2 HSV-2) 9 . After TK 2 HSV-2 infection, both CD4 1 and CD8 1 T cells are primed in the local draining lymph nodes 10 , and both total ( Supplementary Fig. 1a ) and virus-specific ( Supplementary Fig. 1b , c) effector T cells migrate into the vaginal mucosa starting with CD4 1 T cells around day 3-4, followed by CD8 1 T cells on day 4-5. Notably, migration of virus-specific CD8 1 T cells to the infection site was highly dependent on the presence of CD4 1 T cells, evidenced by the failure of CD8 1 T cells to migrate to the local tissue in mice that were either CD4-deficient, or depleted of CD4 1 T cells ( Supplementary Fig. 2a ). However, because primary CTL expansion after HSV-1 infection has been reported to depend on CD4 1 T cells 5 through their ability to license dendritic cells 11 , we examined the total number of congenically marked (CD45.1 1 ) HSV-gB-specific T-cell receptor (TCR) transgenic T cells (gBT-I) 12 generated in Cd4 2/2 and CD4-depeleted mice. Consistent with previous reports 5, 11 , gBT-I responses in various tissues after local HSV-2 infection also depended largely on the presence of CD4 1 T cells ( Supplementary Fig. 2b-d ).
To determine the mechanism by which CD4 1 T cells license CTL migration, fully 'helped' CD8 1 effector T cells were first generated in wild-type hosts ( Fig. 1a ). A physiological number (2 3 10 5 cells per mouse 13 ) of gBT-I cells were transferred into naive wild-type mice. Subsequently, these mice were infected with TK 2 HSV-2, and effector CD8 1 T cells were isolated ( Supplementary Fig. 3a , b) and transferred into recipient mice that had been infected with TK 2 HSV-2 3.5 days earlier. It is well known that effector CTLs migrate to various lymphoid and non-lymphoid organs including the lung, liver and intestine 14, 15 . Accordingly, effector CD8 1 T cells were found in lymphoid and peripheral organs irrespective of the infection status of the host ( Fig. 1b-d ). This homeostatic distribution pattern did not depend on the presence of CD4 1 T cells. In stark contrast, although the fully helped effector CTLs migrated into the infected vaginal tissue in the wild-type hosts, their ability to do so was significantly impaired in the absence of CD4 1 T cells ( Fig. 1e and Supplementary  Fig. 3c ). Similar results were obtained using a different time course ( Supplementary Fig. 4 ). In contrast, adoptively transferred fully helped gBT-I T cells were able to migrate to the HSV-infected vagina in CD8-deficient hosts ( Fig. 1f ), indicating that CD4, but not CD8, T cells are required for licensing CTL entry into the vaginal mucosa. T regulatory (T reg ) cells have been shown to facilitate early protective responses to local HSV-2 infection by allowing a timely entry of immune cells into infected tissue 16 . To examine whether effector or Foxp3 1 CD4 1 T cells account for the mobilization of CTL into the infected vaginal mucosa, either total or Foxp3 2 HSV-primed CD4 1 T cells were adoptively transferred into HSV-infected Cd4 2/2 hosts. The analysis of migration of helped gBT-I cells in such animals showed that effector CD4 1 T cells were equally capable of CTL mobilization into the infected tissue as compared to total CD4 1 T cells (including effectors and T reg cells) ( Supplementary Fig. 5 ). These data indicated that although T reg cells are capable of facilitating effector lymphocyte entry 16 , effector CD4 1 T cells alone mediate CTL recruitment and can override the requirement for T reg cells. Collectively, our results showed that, although homeostatic migration of effector CTLs occurs independently of CD4 1 T-cell help, fully differentiated CTLs are not self-sufficient for accelerated recruitment to the infected tissue during a viral infection. This situation is reminiscent of the requirement for 'pioneering' CD4 1 T cells for entry by pathogenic CD4 1 T cells in the central nervous system 17 .
Furthermore, our data uncovered a previously unknown function of T helper cells in mobilizing CD8 1 T-cell recruitment to the site of infection.
To address the mechanism by which T-cell help enables CTL recruitment to the site of viral replication, we focused on one of the major effector functions of CD4 1 T h 1 cells, namely, the secretion of IFN-c. First, we asked whether CD4-catalysed CTL recruitment was mediated by the action of IFN-c. To this end, CTL migration to the infected tissue in wild-type and Ifngr 2/2 mice was compared. CD8 1 T-cell recruitment to the vagina was significantly reduced in Ifngr 2/2 mice ( Supplementary Fig. 6a ), despite the fact that these mice generated comparable levels of HSV-2-specific CD4 1 and CD8 1 T-cell responses ( Supplementary Fig. 6b , c). Vaginal infection with HSV-2 generates two waves of IFN-c secretion; the first wave of IFN-c is secreted by natural killer (NK) cells at 2 days post infection, whereas CD4 1 T cells produce IFN-c starting at 4 days post infection ( Supplementary Fig. 7a ) 18 . To examine specifically the requirement for CD4 1 T-cell-secreted IFN-c in CTL recruitment, wild-type mice were infected with TK 2 HSV-2, and IFN-c neutralizing antibody was given at 3 and 4 days post infection. With this regimen, NK-secreted IFN-c is not affected, whereas CD4-secreted IFN-c is blocked. Fully helped CD8 1 T cells, when injected into IFN-c neutralized mice, were significantly impaired in their migration to the infected tissue ( Fig. 1e ). Furthermore, NK depletion throughout the course of HSV infection did not alter the recruitment of effector CTL to the vaginal mucosa in either wild-type or Cd4 2/2 hosts ( Supplementary Fig. 8 ). These results, combined with the fact that CD4 1 T cells are required for migration of CTLs, indicated that CTL recruitment primarily, if not exclusively, depends on IFN-c produced by CD4 1 T cells.
To determine whether CD4 1 T cells indeed provide the IFN-c required to pioneer the vaginal mucosa for CTL entry, we tested both sufficiency and requirement for CD4-derived IFN-c in this process. First, to examine the requirement for CD4-derived IFN-c, migration of fully helped gBT-I cells was assessed in Cd4 2/2 mice reconstituted with either wild-type or Ifng 2/2 HSV-primed CD4 1 T cells ( Fig. 2a ). Only the wild-type, and not Ifng 2/2 , effector CD4 1 T cells were able to rescue CTL migration to the site of infection ( Fig. 2a ). These data indicated that IFN-c secretion from CD4 1 T cells is required for CTL entry into the vaginal mucosa after HSV-2 infection. Second, sufficiency of CD4-derived IFN-c in CTL migration was examined by reconstituting Ifng 2/2 mice with either wild-type or Ifng 2/2 HSVprimed CD4 1 T cells. Notably, migration of gBT-I effector cells was facilitated by the presence of wild-type CD4 1 T cells, whereas Ifng 2/2 CD4 1 T cells were only able to promote a basal level of CTL recruitment ( Fig. 2f ). Interestingly, effector CD4 1 T-cell entry into the vaginal tissue also required IFN-c secretion and responsiveness to IFN-c by the CD4 1 T cells themselves ( Supplementary Fig. 9 ), suggesting an autocrine-mediated conditioning of CD4 1 T cells for access to the vaginal mucosa. To address whether IFN-c secretion by CD4 T cells within the vagina is required for CTL entry, we took advantage of the fact that CD4 1 T-cell entry occurs before day 3 post infection, whereas CTL entry is delayed until day 5 post infection ( Supplementary Fig. 1 ). Selective blockade of CD4-secreted IFN-c ( Supplementary Fig. 7a ) on days 3 and 4 of infection still allowed effector CD4 1 T cells to enter the vaginal tissue ( Supplementary  Fig. 10 ). However, this treatment resulted in a significant reduction in CTL migration (Fig. 1e ). These data collectively indicated that CD4 1 T cells that have migrated to the vagina must still produce IFN-c to enable CTL entry to the site. Taken together, our data provide evidence that CD4 1 T-cell-derived IFN-c is both necessary and sufficient in enabling CTL entry to the site of infection.
Next, the requirement for IFN-c-inducible chemokines in CTL recruitment was assessed. To this end, congenically marked gBT-I transgenic mice were crossed to CXCR3-deficient mice incapable of responding to the IFN-c-inducible chemokines, CXCL9 and CXCL10. Physiologically relevant numbers (10 5 (Fig. 2 ) or 10 3 ( Supplementary  Fig. 11 )) of purified CD45.1 1 Cxcr3 2/2 gBT-I cells were transferred into wild-type hosts, and their proliferation and migration was measured 6 days after HSV-2 infection. Cxcr3 2/2 gBT-I cells migrated and proliferated normally in the draining lymph nodes of wild-type hosts (Fig. 3a ). Furthermore, both wild-type and Cxcr3 2/2 gBT-I cells accumulated in the draining lymph nodes ( Fig. 3c and Supplementary  Fig. 11b ), and migrated into the spleen and peripheral tissues (Fig. 3d , e and Supplementary Fig. 11c, d) . In stark contrast, and despite the presence of abundant CD4 1 T h 1 cells in the vaginal mucosa (Fig. 3b ), CXCR3-knockout CTLs failed to migrate into the virally infected vaginal tissue ( Fig. 3f and Supplementary Fig. 11a ). Moreover, the small numbers of Cxcr3 2/2 gBT-I cells that managed to migrate into the vaginal tissue were mostly excluded from the epithelial layer (Fig. 3g )-the primary site of virus infection and replication 10 . Therefore, these data indicated that effector CTL migration into the infected tissue requires CXCR3, whose ligand expression is induced by IFN-c produced by CD4 1 T cells. Host:
Host:
Host: We next asked whether the CD4 1 T cells directly provide help to CD8 1 T cells, or whether CD4 1 T cells control the recruitment of CD8 1 T cells indirectly through modifying the local tissue environment. To address the former possibility, we examined the necessity of CD4 1 T cells for CD8 1 T cells to express and respond through CXCR3. To this end, gBT-I cells were primed in either wild-type or CD4-deficient hosts by intravaginal infection with TK 2 HSV-2, and the expression of CXCR3 was assessed. Although most naive CD8 1 T cells expressed low to undetectable levels of CXCR3, effector gBT-I cells expressed high levels of CXCR3, regardless of the absence of CD4 1 T cells ( Supplementary Fig. 12a ). Furthermore, both helped and helpless CTLs responded to and migrated towards CXCL9 and CXCL10 comparably ( Supplementary Fig. 12b ). These data revealed that CD4 help is not required for the functional expression of CXCR3 by the effector CD8 1 T cells. Therefore, CD4 1 T-cell help is not provided directly to CD8 1 T cells, but is probably mediated through modification of the local microenvironment.
In an effort to understand the mechanism by which CD4 1 T helper cells indirectly enable migration of CD8 1 T cells to the site of infection, we examined the production of CD4-dependent cytokines and chemokines at the local mucosa. As expected, IFN-c levels 4 days after infection were diminished in CD4-deficient mice within the vaginal lumen ( Fig. 4) and within the lamina propria ( Supplementary Fig. 7b ). In the absence of CD4 1 T cells or in mice injected with IFN-c blockingantibody starting at day 3 after infection, secretion of CXCL9 was diminished and a significant reduction in the levels of CXCL10 was observed (Fig. 4) . Thus, cumulative levels of CXCR3 ligands are significantly reduced in the vaginal tissue in the absence of CD4 or IFN-c.
Because CXCL9 and CXCL10 are also induced by type I IFNs, and because we detected a reduced but significant recruitment of residual CTL to the vaginal tissue in the absence of CD4 1 T cells or IFN-c (Figs 1  and 2) , we next assessed the importance of type I IFNs in lymphocyte recruitment after HSV-2 infection. Despite normal priming 19 , CD4 1 T-cell recruitment to the vagina was significantly reduced in the absence of IFN-abR ( Supplementary Fig. 13b ). Consequently, IFN-c, CXCL9 and CXCL10 secretion, and subsequent recruitment of CTL were significantly decreased in IFN-abR-deficient (Ifnar2 2/2 ) mice ( Supplementary Fig. 13c ). Notably, neutralization of IFN-c in Ifnar2 2/2 mice completely abolished CXCL9 and CXCL10 secretion and eliminated the residual CTL recruitment. These data indicated that in the absence of CD4 1 T cells or IFN-c, type I IFNs secreted at the site of infection lead to the production of CXCL10, leading to recruitment of a minor population of CTL to the vagina. However, CD4 1 T cells have a dominant role in guiding effector CTLs to the site of infection. Collectively, these data indicate that CD4 1 T cells mobilize CTLs to the sites of infection by licensing the local tissue environment-by inducing expression of chemokines necessary for CTLs to enter from systemic circulation into the site of infection. We speculate that the source of such chemokines is probably the infected vaginal epithelial cells, as high levels of messenger RNA for both CXCL9 and CXCL10 are detected within the epithelial layer by day 4 post infection (data not shown).
Our study shows that, as well as a crucial involvement in the priming of CD8 1 T cells and in promoting memory CD8 1 T-cell development 1 , CD4 1 T cells serve as gate-keepers of CTL entry into the infected tissues. CD4 1 T cells orchestrate this through the secretion of IFN-c and turning on the expression of chemokines CXCL9 and CXCL10 in situ, which enable the CXCR3 1 effector CTL population to migrate from the peripheral blood into the infected areas. Both of these chemokines have been shown to be important for CTL recruitment and defence against HSV-2 infection 20 . These findings reveal that fully differentiated CTLs are self-insufficient for entry into infected peripheral tissues, and that another layer of regulation is provided by CD4 1 T cells to carry out their effector functions. The many stages in which CD4 help is required for CTL responsesduring priming, memory and now effector phases-probably reflect the need to restrict the cytotoxic activity to the site of infection. In 
WT
i.v. transfer contrast, effector CTL migration into other mucosal tissues, such as the lung and intestine 15 , does not require either CD4 help or inflammation. Thus, certain organs are 'permissible' for effector CTL migration, whereas other organs (for example, vagina) are 'restricted' and rely on CD4 help and inflammatory chemokines to recruit memory of effector T cells only when they are needed. Many pathogens invade the host by establishing local infection before spreading to other organs. The recruitment of the effector lymphocytes to the initial site of microbial entry represents an important challenge in ensuring the protection of the host. Our findings indicate that vaccines that target CTL immunity must incorporate T helper epitopes to allow their migration to the site of infection once the pathogen invades the host. Furthermore, the treatment of CTL-mediated organ-specific autoimmune diseases might benefit from selective depletion of CD4 1 T cells or IFN-c from the local tissue, so as to block further recruitment of pathogenic CTL populations. Future studies to understand the crucial players involved in CD4 1 T-cell-mediated recruitment of effector CTL will help our ability to design effective interventions for treatment of infectious diseases, autoimmunity and cancer.
METHODS SUMMARY
Adoptive transfer of naive CD8 1 T cells and generation of effector gBT-I cells. Indicated numbers of naive gBT-I transgenic CD8 1 T cells from the spleens of CD45.1 1 gBT-I or CD45.1 1 Cxcr3 2/2 gBT-I mice were adoptively transferred into recipient mice. In some experiments, the donor cells were labelled with 0.05 mM CFSE (Invitrogen) before transfer. CD4 1 T cells from recipient mice were depleted by injection of 200 mg GK1.5 antibody (.99.5% depletion). Some recipient mice were injected with neutralizing antibody against IFN-c (intraperitoneally, 1 mg XMG1.2). Depo-Provera-treated 6-8-week-old female recipient mice were infected intravaginally with 10 6 plaque-forming units (p.f.u.) of 186TKDKpn (TK 2 HSV-2) 9 or with uninfected Vero lysate (mock infection) control as described previously 10 . Effector CTLs were isolated from the spleen at 6 days post infection, and transferred into day 4 HSV-2-infected recipients. The numbers of CD45.1 1 gBT-I cells in the primary or secondary hosts were analysed by flow cytometry. Flow cytometry. Single suspensions were prepared from each experimental group using a modified protocol as described 21 . To analyse chemokine receptor expression, cell suspensions were stained with an anti-CXCR3 antibody (220803). The H-2K b -gB498-505 tetramer used here was prepared by the National Institutes of Health (NIH) tetramer core facility. Samples were acquired on a FACSCaliber (BD Bioscience) and analysed with FlowJo software (TreeStar). Cytokine and chemokine measurement in the vaginal wash. The vaginal wash was collected using a standard method 21 . The amount of cytokine/chemokine in the vaginal wash was measured using a multiplex Luminex beads assay (Millipore) or ELISA according to manufacturers' instructions. Four days after HSV-2 infection, vaginal wash was collected from wild-type, Cd4 2/2 mice or mice that were treated with anti-IFN-c antibody on day 3 after infection (as in Fig. 1a ). Cytokine and chemokine concentrations were determined by Luminex bead assay. Data were pooled from two independent experiments (n 5 6) and represented as mean 6 s.e.m. *P , 0.05, **P , 0.01 (one-way analysis of variance (ANOVA) followed by Tukey's post-hoc multiple comparison).
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